TrialThe Lancet. Infectious diseases2023

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial.

Ngoc H Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.